| 产品详情 |
| Edit |   |
|---|
| Product Name | TRAIL, aa261-277, Blocking Peptide (TNF-Related Apoptosis Inducing Ligand, Apo2L, TL2, TNFSF10) |
|---|
| Description | Purified 60-70%. Peptide corresponding to amino acid 261 to 277 of human TRAIL. Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors, TNFR1 and Fas. A novel member in the TNF family was recently identified and designated TRAIL (for TNF-related apoptosis-inducing ligand) and Apo-2L (for Apo-2 ligand)1,2. TRAIL is a type II membrane protein and expressed in a variety of human tissues. Two novel death domain containing receptors DR4 and DR5 have been identified as the receptor for TRAIL3-6. Like TNF and Fas ligand, TRAIL induces apoptosis and NF-kB activation in many tissues and cells. |
|---|
| Size | 50ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | Accession: NP_003801 |
|---|
| Catalog # | T8175P |
|---|
| Price | |
|---|
| Order / More Info | TRAIL, aa261-277, Blocking Peptide (TNF-Related Apoptosis Inducing Ligand, Apo2L, TL2, TNFSF10) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|